These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8369205)

  • 61. Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria.
    Mirmiran A; Poli A; Ged C; Schmitt C; Lefebvre T; Manceau H; Daher R; Moulouel B; Peoc'h K; Simonin S; Blouin JM; Deybach JC; Nicolas G; Puy H; Richard E; Gouya L
    Haematologica; 2021 Mar; 106(3):913-917. PubMed ID: 31919078
    [No Abstract]   [Full Text] [Related]  

  • 62. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [CLINICO-PATHOLOGICAL DESCRIPTION AND NOSOGRAPHIC POSITION OF CONGENITAL PORPHYRIA IN THE PATHOLOGY OF PORPHYRIN METABOLISM. STUDY OF AN UNUSUAL AUTOPSY CASE AND CRITICAL REVIEW OF THE LITERATURE].
    ZAMPI G; PANCONESI E; GIANNOTTI B
    Arch De Vecchi Anat Patol; 1963 Dec; 41():625-94. PubMed ID: 14215155
    [No Abstract]   [Full Text] [Related]  

  • 64. Congenital erythropoietic porphyria.
    Abraham L; Moses PD; Jacob M; Kirubakaran C; George R
    Indian Pediatr; 1995 Jan; 32(1):99-100. PubMed ID: 8617546
    [No Abstract]   [Full Text] [Related]  

  • 65. Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
    Robert-Richard E; Lalanne M; Lamrissi-Garcia I; Guyonnet-Duperat V; Richard E; Pitard V; Mazurier F; Moreau-Gaudry F; Ged C; de Verneuil H
    J Gene Med; 2010 Aug; 12(8):637-46. PubMed ID: 20586119
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phototherapy sequela in a child with congenital erythropoietic porphyria.
    Soylu A; Kavukçu S; Türkmen M
    Eur J Pediatr; 1999 Jun; 158(6):526-7. PubMed ID: 10378407
    [No Abstract]   [Full Text] [Related]  

  • 67. Need for measurement of porphyrins in teardrops in patients with congenital erythropoietic porphyria.
    Takamura N; Kurihara K; Yamashita S; Kondo M
    Br J Ophthalmol; 2002 Oct; 86(10):1188. PubMed ID: 12234907
    [No Abstract]   [Full Text] [Related]  

  • 68. Use of polarized dermoscopy in the evaluation of congenital erythropoietic porphyria.
    Jha A; Pathak J; Sonthalia S; Keshavmurthy V
    Clin Exp Dermatol; 2021 Apr; 46(3):556-557. PubMed ID: 32909623
    [No Abstract]   [Full Text] [Related]  

  • 69. Plasma porphyrins in chronic renal failure.
    Gebril M; Weinkove C; Ead R; McDonald K; Morton R
    Nephron; 1990; 55(2):159-63. PubMed ID: 2362629
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of theophylline toxicity with oral activated charcoal.
    Sessler CN; Glauser FL; Cooper KR
    Chest; 1985 Mar; 87(3):325-9. PubMed ID: 3971756
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Erythrocyte porphyrin and erythrocyte survival in bovine erythropoietic porphyria.
    Kaneko JJ; Zinkl JG; Keeton KS
    Am J Vet Res; 1971 Dec; 32(12):1981-5. PubMed ID: 5131421
    [No Abstract]   [Full Text] [Related]  

  • 73. Porphyrin distribution and porphyrin excretion in human congenital erythropoietic porphyria.
    Eriksen L; Eriksen N
    Scand J Clin Lab Invest; 1974 Jun; 33(4):323-32. PubMed ID: 4853698
    [No Abstract]   [Full Text] [Related]  

  • 74. Role of repeated doses of oral activated charcoal in the treatment of acute intoxications.
    McLuckie A; Forbes AM; Ilett KF
    Anaesth Intensive Care; 1990 Aug; 18(3):375-84. PubMed ID: 2221332
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Congenital erythropoietic porphyria.
    Hamide A; Singh B; Dutta TK; Sridhar MG
    J Indian Med Assoc; 2002 Apr; 100(4):248, 250. PubMed ID: 12405337
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria.
    Grandchamp B; Deybach JC; Grelier M; de Verneuil H; Nordmann Y
    Biochim Biophys Acta; 1980 May; 629(3):577-86. PubMed ID: 7417513
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Congenital erythropoietic porphyria--oral manifestations and dental treatment in childhood: a case report.
    Fayle SA; Pollard MA
    Quintessence Int; 1994 Aug; 25(8):551-4. PubMed ID: 7568703
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transfer.
    Moreau-Gaudry F; Ged C; Barbot C; Mazurier F; Boiron JM; Bensidhoum M; Reiffers J; de Verneuil H
    Hum Gene Ther; 1995 Jan; 6(1):13-20. PubMed ID: 7703283
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria.
    To-Figueras J; Badenas C; Mascaró JM; Madrigal I; Merino A; Bastida P; Lecha M; Herrero C
    Blood Cells Mol Dis; 2007; 38(3):242-6. PubMed ID: 17270473
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of meso-hydroxyuroporphyrin I in the urine of a patient with congenital erythropoietic porphyria.
    Guo R; Rideout JM; Lim CK
    Biochem J; 1989 Nov; 264(1):293-5. PubMed ID: 2604713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.